Characteristics | Number of reports (N = 170,424) | Percentage (%) |
---|---|---|
Age group | Â | Â |
Newborn (0 to 28 d) | 127 | 0.07 |
Infant (29 d to 3 y) | 1,878 | 1.10 |
Child (3 to 12 y) | 2,338 | 1.37 |
Teenager (12 to 18 y) | 10,076 | 5.91 |
Adult (18 to 60 y) | 50,929 | 29.88 |
Elderly (over 60 y) | 24,961 | 14.65 |
Unknown | 80,115 | 47.01 |
Gender | Â | Â |
Male | 67,548 | 39.64 |
Female | 79,438 | 46.61 |
Unknown | 23,438 | 13.75 |
Route of administration | Â | Â |
Oral | 84,666 | 49.68 |
Transdermal | 13,753 | 8.07 |
Intravenous | 5,472 | 3.21 |
Subcutaneous | 4,766 | 2.80 |
Through respiratory tract | 2,870 | 1.68 |
Intramuscular | 1,301 | 0.76 |
Others | 1,868 | 1.10 |
Unknown | 55,728 | 32.70 |
Dosage form | Â | Â |
Tablet | Â | Â |
Conventional tablet | 32,636 | 19.15 |
Sustained/controlled release tablet | 33,232 | 19.50 |
Coated tablet | 5,042 | 2.96 |
Dispersible tablet | 525 | 0.31 |
Chewable tablet | 283 | 0.17 |
Enteric-coated tablet | 138 | 0.08 |
Other tablets | 131 | 0.08 |
Injection | 14,361 | 8.43 |
Gel | 10,131 | 5.94 |
Capsule | 8,110 | 4.76 |
Inhaler | 5,041 | 2.96 |
External dosage form | Â | Â |
Transdermal patch | 2,215 | 1.30 |
Paint | 1,435 | 0.84 |
Drop | 512 | 0.30 |
Other external dosage forms | 242 | 0.14 |
Others | 3,121 | 1.83 |
Unknown | 53,269 | 31.26 |